Norgestrienone
![]() | |
Systematic (IUPAC) name | |
---|---|
17-Hydroxy-19-norpregna-4,9,11-trien-20-yn-3-one | |
Identifiers | |
CAS Number |
848-21-5 ![]() |
ATC code | G03AC07 (WHO) |
PubChem | CID 13313 |
ChemSpider |
12749 ![]() |
UNII |
89386PYU9O ![]() |
KEGG |
D07220 ![]() |
Chemical data | |
Formula | C20H22O2 |
Molar mass | 294.387 g/mol |
| |
| |
![]() ![]() |
Norgestrienone (INN) (brand name Ogyline, Planor), also known as 10,11-didehydro-orethisterone,[1] as well as 17α-ethynyltrienolone (17α-ethynyltrenbolone), is a steroidal progestin that is used as a hormonal contraceptive, sometimes in combination with ethinyl estradiol.[2][3][4] It is a relatively weak progestin, and has some androgenic effects.[5]
Gestrinone is the ethyl derivative of norgestrienone.[6]
References
- ↑ J.P. Lavery; J.S. Sanfilippo (6 December 2012). Pediatric and Adolescent Obstetrics and Gynecology. Springer Science & Business Media. pp. 236–. ISBN 978-1-4612-5064-7.
- ↑ J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 887–. ISBN 978-1-4757-2085-3.
- ↑ I.K. Morton; Judith M. Hall (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 202–. ISBN 978-94-011-4439-1.
- ↑ Diaz, S.; Pavez, M.; Quinteros, E.; Diaz, J.; Robertson, D. N.; Croxatto, H. B. (1978). "Clinical trial with subdermal implants containing norgestrienone". Contraception 18 (4): 429–440. doi:10.1016/0010-7824(78)90027-6. PMID 720075.
- ↑ Julius Axelrod (1 January 1982). Biochemical Actions of Hormones. Academic Press. ISBN 978-0-12-452809-3.
- ↑ Victor Gomel; Andrew Brill (27 September 2010). Reconstructive and Reproductive Surgery in Gynecology. CRC Press. pp. 90–. ISBN 978-1-84184-757-3.
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.